Schubert & Co’s Omnicell OMCL Stock Holding History

Schubert & Co’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12	Closed	-$705	–	1051
2023 Q1	$705	Buy	12 +6	+100%	+$331	﹤0.01%	1318
2022 Q4	$303	Buy	6 +5	+500%	+$300	﹤0.01%	1477
2022 Q3	$0	Sell	1 -11	-92%	-$1.16K	﹤0.01%	1513
2022 Q2	$1K	Buy	12 +6	+100%	+$689	﹤0.01%	1221
2022 Q1	$1K	Sell	6 -2	-25%	-$288	﹤0.01%	839
2021 Q4	$1K	Buy	+8	New	+$1.39K	﹤0.01%	784

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Schubert & Co's OMCL Position: Q2 2023 in Review

Schubert & Co sold out of Omnicell (OMCL) in Q2 2023, closing a stake of 12 shares — an estimated $705 sold.

Schubert & Co first reported a position in OMCL in Q4 2021 and held it in 6 quarters. The position peaked at $1K in Q2 2022. 313 funds tracked by Wall St. Rank hold OMCL as of Q2 2023.

Schubert & Co reported no remaining Omnicell position as of Q2 2023 after selling out during the quarter.
Schubert & Co sold 12 Omnicell shares in Q2 2023, an estimated $705.
Schubert & Co first reported a position in Omnicell in Q4 2021 and held it in 6 quarters.
Schubert & Co's Omnicell position peaked at $1K in Q2 2022.
313 funds tracked by Wall St. Rank held Omnicell as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.